Global Oral Thin Films Market Driven by Rising Adoption of Patient-Centric Drugs and Increasing Regulatory Approvals for Novel Drug Delivery Formats

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Oral Thin Films Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

 

According to the report, the market is valued at USD 3.80 billion in 2026, which is expected to grow to USD 7.93 billion by 2034. The projected CAGR for this period is 9.62%.

The oral thin films market is segmented based on product, disease indication, distribution channel, and region. Some of the insights provided in the report are highlighted below:

• The schizophrenia segment dominated the market with the largest share of 32.55% in 2025.
• North America is expected to lead the oral thin films market during the forecast period, supported by a well-established pharmaceutical and biotechnology industry, high healthcare spending, and favorablereimbursement structures that encourage the adoption of advanced drug delivery systems.
• Globally, pharmaceutical manufacturers and healthcare providers are increasingly shifting from conventional solid oral dosage forms to fast-dissolving and patient-centric drug delivery systems such as oral thin films, driven by the need for improved medication adherence, faster onset of action, and better therapeutic outcomes across pediatric, geriatric, and chronic disease populations.
• India is expected to emerge as a key market within the Asia Pacific oral thin films landscape, driven by increasinggovernment support for domestic drug production, improving healthcare access in tier-2 and tier-3 cities, and strong export capabilities of pharmaceutical companies.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

1. By Product
   1. Sublingual Film
   2. Fast Dissolving Dental/Buccal Film
2. By Disease Indication
   1. Schizophrenia
   2. Migraine
   3. Opioid Dependence
   4. Nausea and Vomiting
   5. Others
3. By Distribution Channel
   1. Hospital Pharmacies
   2. Retail Pharmacies
   3. Online Pharmacies
4. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East & Africa
   5. Latin America